Mistral raises $3.3B, Insilico's anti-aging AI drug & more

Tech & AI Brief · Sep 8, 2026 · 5m

Major capital floods the generative AI landscape as Mistral AI and Thinking Machines Lab secure multibillion-dollar funding rounds led by industry giants. Meanwhile, Insilico Medicine achieves a major milestone with an AI-designed drug reversing biological age in clinical trials. Plus, OpenAI introduces an AI research intern capability to accelerate scientific discovery. Full edition: https://tech.pibrief.com/editions/2026-09-08